Receptor for age (RAGE) is a gene within the major histocompatibility class III region: implications for host response mechanisms in homeostasis and chronic disease.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Frontiers in Bioscience

• Publication date

  2001-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2741/SCHMIDTPMID 11578972
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Ne-(carboxymethyl) lysine independently of glycohaemoglobin concentrations

  1999cited by this paper
• The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation.

  1999cited by this paper
• Human RAGE GLY82SER dimorphism and HLA class II DRB1-DQA1-DQB1 haplotypes in type 1 diabetes.

  1999cited by this paper
• N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression*

  1999cited by this paper
• Receptor for Advanced Glycation End Products (RAGE)-mediated Neurite Outgrowth and Activation of NF-κB Require the Cytoplasmic Domain of the Receptor but Different Downstream Signaling Pathways*

  1999cited by this paper
• RAGE Gly82Ser polymorphism in diabetic microangiopathy.

  1999cited by this paper
• Association of G82S polymorphism in the RAGE gene with skin complications in type 2 diabetes.

  1999cited by this paper
• RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides.

  1999influential reference
• HMG-1 as a late mediator of endotoxin lethality in mice.

  1999cited by this paper
• Cloning and expression of human corneal calgranulin C (CO-Ag).

  1998cited by this paper
• Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

  1998influential reference
• Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups.

  1998cited by this paper
• Sp1-binding Elements in the Promoter of RAGE Are Essential for Amphoterin-mediated Gene Expression in Cultured Neuroblastoma Cells*

  1998cited by this paper
• Cloning and sequence analysis of human and bovine corneal antigen (CO-Ag) cDNA: identification of host-parasite protein calgranulin C.

  1997cited by this paper
• Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

  1997cited by this paper
• Characterization and Functional Analysis of the Promoter of RAGE, the Receptor for Advanced Glycation End Products*

  1997cited by this paper
• Amyloid- (cid:98) peptide–Receptor for Advanced Glycation Endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: A proinflammatory pathway in Alzheimer disease

  1997cited by this paper
• Activation of the Receptor for Advanced Glycation End Products Triggers a p21 ras -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress*

  1997cited by this paper
• N[ε]-(Carboxymethyl)lysine Protein Adduct Is a Major Immunological Epitope in Proteins Modified with Advanced Glycation End Products of the Maillard Reaction(カルボキシメチルリジン付加体はメイラード反応後期生成物の主要エピトープある)

  1997cited by this paper
• RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.

  1996cited by this paper
• HLA-DQB1*0201/0302 is associated with severe retinopathy in patients with IDDM

  1996cited by this paper
• The Advanced Glycation End Product, N-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactions (*)

  1996cited by this paper
• Increased atherosclerosis in streptozotocin-induced diabetic mice.

  1996cited by this paper
• The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis.

  1996cited by this paper
• Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats.

  1996cited by this paper
• A novel calcium-binding protein in amniotic fluid, CAAF1: its molecular cloning and tissue distribution.

  1996cited by this paper
• The S100 family of EF-hand calcium-binding proteins: functions and pathology.

  1996cited by this paper
• N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction.

  1996cited by this paper
• The myeloic related protein MRP8/14 (27E10 antigen)— usefulness as a potential marker for disease activity in ulcerative colitis and putative biological function

  1995cited by this paper
• The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin

  1995cited by this paper
• N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins.

  1995cited by this paper
• The S100 protein family: history, function, and expression.

  1995cited by this paper
• Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins.

  1994cited by this paper
• Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3.

  1994influential reference
• Literature Reviews: Endocrinology

  1994cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products.

  1993cited by this paper
• Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues.

  1993cited by this paper
• Accumulation of Maillard reaction products in skin collagen in diabetes and aging.

  1993cited by this paper
• Genetic Marker Associations With Proliferative Retinopathy in Persons Diagnosed With Diabetes Before 30 yr of age

  1992cited by this paper
• Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.

  1992cited by this paper
• Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.

  1992cited by this paper
• Accumulation of Maillard Reaction Products in Skin Collagen in Diabetes and Aging a

  1992cited by this paper
• Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface.

  1992cited by this paper
• Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.

  1992cited by this paper
• The adhesive and neurite-promoting molecule p30: analysis of the amino- terminal sequence and production of antipeptide antibodies that detect p30 at the surface of neuroblastoma cells and of brain neurons

  1988cited by this paper
• Isolation and some characteristics of an adhesive factor of brain that enhances neurite outgrowth in central neurons.

  1987cited by this paper
• Rapid Publication

  1971cited by this paper
• lnterleukin-10-Deficient Mice Develop Chronic Enterocolitis

  year unknowncited by this paper

• Role of the receptor for advanced glycation end products in the severity of SARS-CoV-2 infection in diabetic patients

  2024cites this paper
• Comprehending the Rationale for Repurposing Type 2 Diabetes Mellitus Medicines for Alzheimer's Disease Patients Via Gene Networks Studies and its Associated Molecular Pathways

  2024cites this paper
• Advanced glycation end products of dietary origin and their association with inflammation in diabetes – A minireview

  2024cites this paper
• Wound Healing Efficacy of Cucurbitaceae Seed Oils in Rats: Comprehensive Phytochemical, Pharmacological, and Histological Studies Tackling AGE/RAGE and Nrf2/Ho-1 Cue

  2024cites this paper
• Oxytocin Dynamics in the Body and Brain Regulated by the Receptor for Advanced Glycation End-Products, CD38, CD157, and Nicotinamide Riboside

  2022cites this paper
• Role of RAGE in the Pathogenesis of Neurological Disorders

  2022cites this paper
• Receptor for Advanced Glycation End-Products Promotes Activation of Alveolar Macrophages through the NLRP3 Inflammasome/TXNIP Axis in Acute Lung Injury

  2022cites this paper
• The relationship between endogenous secretory RAGE and cardiac autonomic function in prediabetes

  2021cites this paper
• AGE-RAGE System and its Application in Stem Cell Therapy

  2021cites this paper
• Inhibition of the Receptor for Advanced Glycation End Products Enhances the Cytotoxic Effect of Gemcitabine in Murine Pancreatic Tumors

  2021cites this paper
• RAGE Signaling in Melanoma Tumors

  2020cites this paper
• Cell invasion, RAGE expression, and inflammation in oral squamous cell carcinoma (OSCC) cells exposed to e‐cigarette flavoring

  2020cites this paper
• Advanced Glycation End Products and Receptor (RAGE) Promote Wound Healing of Human Corneal Epithelial Cells

  2020cites this paper
• Receptor for Advanced Glycation End Products Acts as a Fuel to Colorectal Cancer Development

  2020cites this paper
• Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome

  2019cites this paper
• RAGE and its emerging role in the pathogenesis of Parkinson's disease.

  2018cites this paper
• Limonene: Aroma of innovation in health and disease.

  2018cites this paper
• The Effect of Chronic Cerebral Hypoperfusion on Amyloid-β Metabolism in a Transgenic Mouse Model of Alzheimer’s Disease (PS1V97L)

  2018cites this paper
• 2 Aging and Bone

  2018cites this paper
• Susceptibility genes for diabetic retinopathy

  2017cites this paper
• Aging alters mRNA expression of amyloid transporter genes at the blood-brain barrier.

  2017cites this paper
• HMGB1, S100 proteins and other RAGE ligands in cancer - markers, mediators and putative therapeutic targets.

  2016cites this paper
• Role of RAGE in melanoma development, growth, and progression

  2016cites this paper
• HMGB1 Promotes Intraoral Palatal Wound Healing through RAGE-Dependent Mechanisms

  2016cites this paper
• Advanced Glycation Endproducts (AGEs) and Chronic Complications in Diabetes

  2016cites this paper
• Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women

  2015cites this paper
• Receptor for advanced glycation end-products regulates lung fluid balance via protein kinase C-gp91(phox) signaling to epithelial sodium channels.

  2015cites this paper
• The Vertebrate Blood-Gas Barrier in Health and Disease

  2015cites this paper
• Transbarrier Ion and Fluid Transport

  2015cites this paper
• The role of RAGE in the diabetic neuropathy

  2015cites this paper
• Expression pattern of RAGE and IGF-1 in the human fetal ovary and ovarian serous carcinoma.

  2015cites this paper
• Emerging role of HMGB1 in fibrotic diseases

  2014cites this paper
• Alzheimer’s Disease and Type 2 Diabetes: Multiple Mechanisms Contribute to Interactions

  2014cites this paper
• Overexpression of Receptor for Advanced Glycation End Products and High-Mobility Group Box 1 in Human Dental Pulp Inflammation

  2014cites this paper
• The Receptor for Advanced Glycation End Products (RAGE) Specifically Recognizes Methylglyoxal-Derived AGEs

  2014cites this paper
• Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress.

  2014cites this paper
• Voltammetric Detection of S100B Protein Using His-Tagged Receptor Domains for Advanced Glycation End Products (RAGE) Immobilized onto a Gold Electrode Surface

  2014cites this paper
• [Receptor of advanced glycation endproducts RAGE/AGER: an integrative view for clinical applications].

  2014cites this paper
• The receptor for advanced glycation end products influences the expression of its S100 protein ligands in melanoma tumors.

  2014cites this paper
• The Emerging Role of the Receptor for Advanced Glycation End Products on Innate Immunity

  2014cites this paper
• RAGE, inflammation and oral cancer: recreating the connexion.

  2014cites this paper
• The immunobiology of the receptor of advanced glycation end-products: trends and challenges.

  2013cites this paper
• The receptor for advanced glycation end-products: a complex signaling scenario for a promiscuous receptor.

  2013cites this paper
• Novel non-canonical TGF-β signaling networks: emerging roles in airway smooth muscle phenotype and function.

  2013cites this paper
• Cardiovascular risk and its determinants in high risk patients

  2012cites this paper
• Advanced Glycation Endproduct Crosslinking in the Cardiovascular System

  2012cites this paper
• Interaction effect between the receptor for advanced glycation end products (RAGE) and high-mobility group box-1 (HMGB-1) for the migration of a squamous cell carcinoma cell line.

  2011cites this paper
• Diabetes and cancer: Looking at the multiligand/RAGE axis.

  2011cites this paper
• AGE restriction in diabetes mellitus: a paradigm shift

  2011cites this paper
• On the in vivo early toxic properties of A-beta 25-35 peptide in the rat hippocampus: involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression.

  2011cites this paper
• Aging kidney: modern perspectives for an ‘old’ problem

  2011cites this paper
• Advanced glycation end product recognition by the receptor for AGEs.

  2011cites this paper
• Interaction Effect between the Receptor for Advanced Glycation End Products (RAGE) and High-Mobility Group Box-1 (HMGB-1) for the Migration of a Squamous Cell Carcinoma Cell Line

  2011cites this paper
• RAGE: a multi-ligand receptor unveiling novel insights in health and disease.

  2010cites this paper
• Modulation of Nitric Oxide Pathway by Multiligands/RAGE Axis: A Crossing Point on the Road to Microvascular Complication in Diabetes

  2010cites this paper
• Amyloid Deposition and Influx Transporter Expression at the Blood-Brain Barrier Increase in Normal Aging

  2010cites this paper
• Fueling inflammation at tumor microenvironment: the role of multiligand/RAGE axis.

  2010cites this paper
• Pentoxifylline alleviates high-fat diet-induced non-alcoholic steatohepatitis and early atherosclerosis in rats by inhibiting AGE and RAGE expression

  2010cites this paper
• An evaluation of the effect of a topical product containing C‐xyloside and blueberry extract on the appearance of type II diabetic skin

  2009cites this paper
• Gene Expression Profiling in Human Acute Ischemic Stroke

  2009cites this paper
• Aging and Bone

  2009cites this paper
• Hyperglycemia and Glycation in Diabetic Complications

  2009cites this paper
• Cytokines: monitors of disease severity for the clinic.

  2009cites this paper
• Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions.

  2009cites this paper
• Alternative and additional mechanisms to the hygiene hypothesis

  2009cites this paper
• Skin autofluorescence in diabetes mellitus

  2008cites this paper
• RAGE: una nuova via pro-infiammatoria per le polmoniti interstiziali?

  2008cites this paper
• Structural Basis for Pattern Recognition by the Receptor for Advanced Glycation End Products (RAGE)*

  2008cites this paper
• Interleukin-1 Family of Cytokines and Cancer

  2007cites this paper
• 19 2 Aging and Bone

  2007cites this paper
• Masquerader: High Mobility Group Box-1 and Cancer

  2007cites this paper
• Structural insights into signal-transducing proteins : Regulation of the EF-hand protein S100A2 and activation of the Receptor for Advanced Glycation Endproducts

  2007cites this paper
• 2 and Bone

  2007cites this paper
• Linking stress to inflammation.

  2006cites this paper
• Posttranslationally modified proteins as mediators of sustained intestinal inflammation.

  2006cites this paper
• High-mobility group box 1 (HMGB1) protein: friend and foe.

  2006cites this paper
• Plasma Levels of Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease in Nondiabetic Men

  2005cites this paper
• Infectivity of Hepatic Strain Klebsiella pneumoniae in Diabetic Mice

  2005cites this paper
• Transglycation—A Potential New Mechanism for Deglycation of Schiff's Bases

  2005cites this paper
• Inflammation und Verlust der Nozizeption bei diabetischer Neuropathie

  2005cites this paper
• Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes—the EURODIAB Prospective Complications Study

  2005cites this paper
• S100P Stimulates Cell Proliferation and Survival via Receptor for Activated Glycation End Products (RAGE)*

  2004cites this paper
• Serum albumin induces iNOS expression and NO production in RAW 267.4 macrophages

  2004influential citation
• Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response.

  2004cites this paper
• The clinical relevance of advanced glycation endproducts (AGE) and recent developments in pharmaceutics to reduce AGE accumulation.

  2004cites this paper
• Extracellular role of HMGB1 in inflammation and sepsis

  2004cites this paper
• Chromosomal HMG-box proteins

  2004cites this paper
• CHAPTER 39 – HMGB-1

  2003cites this paper
• Anti-Aging Medicine LiteratureWatch

  2002cites this paper
• Regulation of smooth muscle cell accumulation in diabetes-accelerated atherosclerosis.

  2002cites this paper
• Chemico-Biological Interactions

  year unknowncites this paper